Acknowledgements
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1669-1669. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Pharmacogenetics of neural injury recovery
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1635-1643. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Relationship between CYP2D6 genotype and haloperidol pharmacokinetics and extrapyramidal symptoms in healthy volunteers
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1551-1563. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 update
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1659-1667. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Impact of biomarkers on clinical trial risk
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1645-1658. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Pharmacogenetics of antiplatelets and anticoagulants: a report on clopidogrel, warfarin and dabigatran
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1565-1572. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Long-term effects of ABCB1 and SXR SNPs on the systemic exposure to cyclosporine in pediatric kidney transplant patients
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1605-1613. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Making data on essential pharmacogenes available for every patient everywhere: the Medicine Safety Code initiative
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1529-1531. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Impact of genotype-guided dosing on anticoagulation visits for adults starting warfarin: a randomized controlled trial
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1593-1603. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Transporter pharmacogenetics: do we need function? Do we need motion?
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1537-1540. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Pharmacogenetics of topical and systemic treatment of psoriasis
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1623-1634. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Comparative study of polymorphism frequencies of the CYP2D6, CYP3A5, CYP2C8 and IL-10 genes in Mexican and Spanish women with breast cancer
Pharmacogenomics , October 2013, Vol. 14, No. 13, Pages 1583-1592. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - October 2, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Effect of NR3C2 genetic polymorphisms on the blood pressure response to enalapril treatment
Pharmacogenomics , Ahead of Print, Pages 1-8. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 24, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Efficacy of electroconvulsive therapy: is it in the BDNF gene?
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1365-1368. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 12, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Acknowledgements
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1527-1527. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

RRM1 and RRM2 pharmacogenetics: association with phenotypes in HapMap cell lines and acute myeloid leukemia patients
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1449-1466. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

ABCC11/MRP8 polymorphisms affect 5-fluorouracil-induced severe toxicity and hepatic expression
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1433-1448. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Impact of CYP3A5 genotype on tacrolimus versus midazolam clearance in renal transplant recipients: new insights in CYP3A5-mediated drug metabolism
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1467-1480. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

News & Views ...Pharmacogenomics
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1373-1376. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Donor–recipient genetic diversity: the role of
pharmacogenomics in kidney transplantation
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1369-1372. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

CYP2C9 and ABCG2 polymorphisms as risk factors for developing adverse drug reactions in renal transplant patients taking fluvastatin: a case–control study
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1419-1431. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Institutional Profile: University of Chicago Center for Personalized Therapeutics: research, education and implementation science
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1383-1387. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Human dopamine transporter gene: differential regulation of 18-kb haplotypes
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1481-1494. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Multiomics medicine in oncology: assessing effectiveness, cost–effectiveness and future research priorities for the molecularly unique individual
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1405-1417. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

A clinical conundrum: the detrimental effect of TNF antagonists in multiple sclerosis
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1397-1404. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Irreversible hepatotoxicity after administration of trabectedin to a pleiomorphic sarcoma patient with a rare ABCC2 polymorphism: a case report
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1389-1396. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Pharmacogenetics of paraoxonase activity: elucidating the role of high-density lipoprotein in disease
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1495-1515. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Research Highlights: Pharmacokinetic and dynamic genetic risk factors for QT prolongation with iloperidone therapy
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1377-1381. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Tailoring mTOR-based therapy: molecular evidence and clinical challenges
Pharmacogenomics , September 2013, Vol. 14, No. 12, Pages 1517-1526. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - September 11, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Pharmacogenetic labyrinth of neovascular age-related macular degeneration therapy: how to escape and move forward?
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1239-1242. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 10, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Cancer heterogeneity and signaling network-based drug target
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1243-1246. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Genetic variation in the PPARA gene is associated with simvastatin-mediated cholesterol reduction in the Rotterdam Study
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1295-1304. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Effects of polymorphisms in ABCG2, SLCO1B1, SLC10A1 and CYP2C9/19 on plasma concentrations of rosuvastatin and lipid response in Chinese patients
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1283-1294. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

DPYD IVS14+1G>A and 2846A>T genotyping for the prediction of severe fluoropyrimidine-related toxicity: a meta-analysis
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1255-1272. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Implications of the incidentalome for clinical pharmacogenomics
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1353-1362. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Current approaches for TYMS polymorphisms and their importance in molecular epidemiology and pharmacogenetics
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1337-1351. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Pharmacogenetics of olanzapine metabolism
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1319-1336. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Triptolide, a Chinese herbal extract, enhances drug sensitivity of resistant myeloid leukemia cell lines through downregulation of HIF-1α and Nrf2
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1305-1317. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

News & Views
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1247-1250. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Role of ethnicity in antipsychotic-induced weight gain and tardive dyskinesia: genes or environment?
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1273-1281. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Acknowledgements
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1363-1363. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Research Highlights
Pharmacogenomics , August 2013, Vol. 14, No. 11, Pages 1251-1253. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - August 9, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Incorporating psychiatric pharmacogenetics into family practice
Pharmacogenomics , July 2013, Vol. 14, No. 10, Pages 1121-1124. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - July 17, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Impact of pharmacogenetics on CNS side effects related to efavirenz
Pharmacogenomics , July 2013, Vol. 14, No. 10, Pages 1167-1178. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - July 16, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

OCT1 genetic variants influence the pharmacokinetics of morphine in children
Pharmacogenomics , July 2013, Vol. 14, No. 10, Pages 1141-1151. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - July 16, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

A massive open online course on pharmacogenomics: not just disruptive innovation but a possible solution
Pharmacogenomics , July 2013, Vol. 14, No. 10, Pages 1125-1127. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - July 16, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Research Highlights: Highlights from the latest articles in pharmacogenomics
Pharmacogenomics , July 2013, Vol. 14, No. 10, Pages 1137-1139. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - July 16, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Mobilizing pharmacogenomic analyses during clinical trials in drug development
Pharmacogenomics , July 2013, Vol. 14, No. 10, Pages 1227-1235. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - July 16, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Acknowledgements
Pharmacogenomics , July 2013, Vol. 14, No. 10, Pages 1237-1237. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - July 16, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research

Pharmacogenetics of chronic obstructive pulmonary disease
Pharmacogenomics , July 2013, Vol. 14, No. 10, Pages 1215-1225. (Source: Future Medicine: Pharmacogenomics)
Source: Future Medicine: Pharmacogenomics - July 16, 2013 Category: Genetics & Stem Cells Tags: article Source Type: research